Drug Topics

SEPTEMBER 8, 2022

Addressing patient concerns about cannabidiol can be the key to patient satisfaction.

529

529

PharmaVoice

SEPTEMBER 8, 2022

Supply chain challenges, labor shortages and increased FDA inspections are boosting recall risks — but careful planning can keep companies in the clear.

FDA 245

FDA 245

Drug Topics

SEPTEMBER 8, 2022

Encouraging outcomes in recent studies have researchers calling for more analysis of the effect of cannabinoids on sleep disorders.

503

503

STAT

SEPTEMBER 8, 2022

At the end of an unusual and dramatic meeting on Wednesday, an independent panel of advisers to the Food and Drug Administration recommended the approval of a new drug to treat people with ALS developed by Amylyx Pharmaceuticals. The vote was 7-2, a substantial margin of support for the Amylyx drug called AMX0035 and a reversal of the same group’s vote against the drug last March.

FDA 145

FDA 145

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmaceutical Technology

SEPTEMBER 8, 2022

Tetra Bio-Pharma and Cellvera have entered an agreement to jointly develop ARDS-003 as an oral combination therapeutic candidate with 400mg Qifenda (Favipiravir) for Covid-19. A first-in-human drug product, ARDS-003 contains the active pharmaceutical agent, Onternabez. Onternabez is a selective full agonist of the type 2 cannabinoid receptor (CB2R).

Pharmaceutical Companies 132

Pharmaceutical Companies Pharmaceutical Companies Immunization 132

STAT

SEPTEMBER 8, 2022

A daily dose of Relay Therapeutics’ experimental drug for cholangiocarcinoma, a rare cancer of the bile ducts, led to tumor shrinkage of a third or more in 15 of 17 patients with metastatic disease, the company said Wednesday. The results were released in an abstract at the annual meeting of the European Society of Molecular Oncology, where they will be presented in full on Sunday.

143

143

STAT

SEPTEMBER 8, 2022

As a woman of color who was fortunate to be accepted to medical school 29 years ago, I thought that if I had the intelligence, grit, and credentials, I would succeed. I thought that the profession of medicine operated within a system of meritocracy: work hard and you will be rewarded. I learned the hard way that it isn’t like that. My post-graduate professional journey has spanned a general surgery residency, fellowships in hospice and palliative medicine and clinical medical ethics, all

Medical Schools 124

Medical Schools 124

Pharmacy Times

SEPTEMBER 8, 2022

Patients should discuss efficacy and potential drug interactions with clinicians before use, study authors indicate.

132

132

Pharmaceutical Technology

SEPTEMBER 8, 2022

Roche has signed a definitive merger agreement for the acquisition of US-based biopharmaceutical company Good Therapeutics for an upfront payment of $250m in cash. Good Therapeutics focuses on the development of PD-1-regulated IL-2 drugs that are based on innovative conditionally active drug technology. With the takeover, Roche will attain rights to a conditionally active, PD-1-regulated IL-2 programme of Good Therapeutics.

Immunization 111

Immunization 111

Pharmacy Times

SEPTEMBER 8, 2022

Pharmacists handle public vaccination efforts and need to assess where patients are on the hesitancy spectrum to provide reliable information.

Vaccines 132

Vaccines 132

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

SEPTEMBER 8, 2022

UnitedHealth Group is poised to widen its lead in the Medicare Advantage market through a partnership with the retail giant Walmart. The two companies announced a multifaceted, 10-year partnership Wednesday that will kick off in January with a co-branded Medicare Advantage plan in Georgia. UnitedHealth will also help Walmart Health clinics manage care for all of their Medicare Advantage patients, regardless of insurer, starting with 15 locations in Georgia and Florida and growing from there.

Clinic Management 108

Clinic Management Insurance Hospitals 108

Pharmacy Times

SEPTEMBER 8, 2022

Pharmacy managers should have recommendations for how staff pharmacists and even technicians will improve the education and mentoring of future pharmacists.

131

131

Drug Store News

SEPTEMBER 8, 2022

Available in Frosted Flakes, Froot Loops, Apple Jacks and Raisin Bran Crunch, each portable bowl is pre-portioned, and features instant milk, the company said.

106

106

Pharmacy Times

SEPTEMBER 8, 2022

Nintedanib is a tyrosine kinase inhibitor targeting key receptors involved in signaling pathways that led to pulmonary fibrosis.

123

123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

pharmaphorum

SEPTEMBER 8, 2022

Asking patients with chronic conditions to regularly inject themselves can be challenging, causing needle anxiety and worry that they may not carry out the procedure correctly, which can reduce compliance. Now, a partnership between Ypsomed and Sidekick Heath aims to tackle that problem. Ypsomed is a top developer of injection and infusion systems, so knows a lot about the difficulties that patients can face when getting to grips with these medical devices, particularly when they are just starti

Communication 105

Communication 105

Pharmacy Times

SEPTEMBER 8, 2022

Dupilumab is used as a maintenance therapy when added to other asthma medications.

123

123

Drug Store News

SEPTEMBER 8, 2022

The company appointed Inderpal Bhandari to its board of directors and named Hsiao Wang senior vice president and chief information officer.

105

105

Pharmacy Times

SEPTEMBER 8, 2022

Obesity, heavy alcohol consumption, and coagulopathy were some of the greatest risk factors associated with patients returning to the operating room within 48 hours of a surgery.

123

123

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

SEPTEMBER 8, 2022

The passage of the Inflation Reduction Act brings a new era to drug pricing in the United States. After decades of being an outlier, it now joins every other developed nation in having the federal government engaged in negotiating drug pricing. The pharmaceutical industry will continue its fight to blunt the implementation of the law, but in coming years Medicare prices for a limited number of high-cost medications will be lowered, with new prices established either through steep discounts off t

Insurance 104

Insurance 104

Pharmacy Times

SEPTEMBER 8, 2022

Findings have implications for patients who take supplementary folate to prevent complications of other pharmacological therapies.

121

121

STAT

SEPTEMBER 8, 2022

WASHINGTON – On Tuesday, a group of more than 30 attorneys general announced they had reached a “landmark” $438.5 million settlement with the e-cigarette maker Juul over its alleged marketing toward children. Tobacco control advocates had hoped the settlement would compare to the historic one reached two decades earlier between states and cigarette companies, a multi-billion dollar deal that changed the way tobacco companies marketed their products forever.

104

104

European Pharmaceutical Review

SEPTEMBER 8, 2022

Researchers have developed a simple, fast and cost-effective ultraviolet (UV) spectroscopy-based method that could act as a process analytical technology (PAT) to enable integrated or continuous downstream protein purification operations. As the industry works to establish continuous bioproduction/bioprocessing in hopes of realising the benefits of reduced process costs and increased flexibility to cope with demand, the development of PAT tools that can provide real-time measurements and support

98

98

STAT

SEPTEMBER 8, 2022

WASHINGTON — Washington’s attempts to permanently lock in telehealth coverage have been hobbled by a fear that virtual care could drive up Medicare fraud and spending. But a new watchdog report offers  early evidence that only a small portion of providers are billing for virtual care in a potentially fraudulent way, suggesting that targeted interventions could crack down on abuse.

104

104

Drug Store News

SEPTEMBER 8, 2022

The new e-commerce capabilities will provide customers with in-store prices and delivery in two hours or less, the company said.

98

98

STAT

SEPTEMBER 8, 2022

Amid ongoing controversy over clinical trial transparency, a new analysis found that just 3% of the more than 3,700 studies run exclusively in Canada over a recent 10-year period were registered prospectively, reported results, and published the findings. More specifically, 47% of those trials, or more than 1,770, were registered in advance, while only 12% reported results in a registry and 48% published their findings.

98

98

European Pharmaceutical Review

SEPTEMBER 8, 2022

“The most exciting finding of the study is the robustness of the signal in the cluster-interval data,” noted co-author and Assistant Professor of Neurology at Harvard Medical School, US, Dr Jurriaan Peters. “The results consistently showed a clinical and statistical increase in the time between use of intranasal diazepam, Valtoco, over time.

Medical Schools 98

Medical Schools 98

STAT

SEPTEMBER 8, 2022

Running clinical trials remotely or virtually can provide substantial financial savings for pharmaceutical companies, according to a new pilot study. And the findings may prompt still further use of such techniques, which have been increasingly adopted during the Covid-19 pandemic. Specifically, remote or virtual methods — such as telemedicine and the use of other mobile devices — yielded a five-fold return on investment of $8.6 million, on average, for Phase 2 clinical trials.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

Drug Store News

SEPTEMBER 8, 2022

Debbie Weitzman, president of pharmaceutical distribution, will become the CEO of Cardinal Health's pharmaceutical segment, succeeding Victor Crawford who will step down.

98

98

STAT

SEPTEMBER 8, 2022

Is Illumina a victim of its own success? What makes the FDA change its mind? And how will petrodollars change biotech? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Matthew Herper joins us to discuss how Illumina, the biggest company in genomic sequencing, got into an $8 billion predicament.

FDA 98

FDA 98

PharmExec

SEPTEMBER 8, 2022

Barnes discusses alternative reimbursement plans for expensive, one-off therapies.

98

98

STAT

SEPTEMBER 8, 2022

You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences.  Sign up to get this newsletter  delivered in your inbox every Tuesday and Thursday.  Just how much telehealth fraud is there?

98

98

Drug Store News

SEPTEMBER 8, 2022

The company announced a definitive agreement to acquire Hero’s acne care products, including the Hero Mighty Patch brand, for $630 million.

98

98

Pharmacy Times

SEPTEMBER 8, 2022

Children younger than age 6 years might be protected from other COVID-19 variants for up to a year after infection.

Immunization 94

Immunization 94